Cargando…

Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination

INTRODUCTION: The aim of this retrospective case control study was to identify predictors of ovarian response and pregnancy outcomes in intrauterine insemination (IUI). MATERIAL AND METHODS: One hundred women undergoing IUI cycles with clomiphene citrate were enrolled. The number of antral follicles...

Descripción completa

Detalles Bibliográficos
Autores principales: Oner, Gokalp, Ulug, Pasa, Elmali, Ferhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697041/
https://www.ncbi.nlm.nih.gov/pubmed/26788087
http://dx.doi.org/10.5114/aoms.2014.41167
_version_ 1782407875855908864
author Oner, Gokalp
Ulug, Pasa
Elmali, Ferhan
author_facet Oner, Gokalp
Ulug, Pasa
Elmali, Ferhan
author_sort Oner, Gokalp
collection PubMed
description INTRODUCTION: The aim of this retrospective case control study was to identify predictors of ovarian response and pregnancy outcomes in intrauterine insemination (IUI). MATERIAL AND METHODS: One hundred women undergoing IUI cycles with clomiphene citrate were enrolled. The number of antral follicles and the total ovarian volume by ultrasound, and the basal levels of follicle-stimulating hormone (FSH), estradiol, and inhibin B on cycle day 3 were measured in groups that were divided according to ovarian response. The tests were also evaluated according to ovarian response and pregnancy outcomes. All analyses were performed using the Statistical Package for the Social Sciences, version 15.0 (SPSS, Chicago, IL, USA). RESULTS: The antral follicle count (AFC) was the best single predictor for ovarian response and pregnancy outcomes. The sensitivity and specificity for prediction of ovarian response were 81% and 78% for AFC at an optimum cutoff value of ≤ 13.1. Age was negatively correlated with ovarian volume (r = –0.280, p = 0.021) and AFC (r = –0.358, p = 0.003). Increasing FSH was associated with a reduction in AFC (r = –0.273, p = 0.025). The AFC was significantly correlated with ovarian volume (r = 0.660, p < 0.0001) and FSH (r = –0.273, p = 0.03). CONCLUSIONS: Our data demonstrate that the AFC provides better prognostic information on the occurrence of ovarian response during clomiphene citrate stimulation for IUI.
format Online
Article
Text
id pubmed-4697041
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-46970412016-01-19 Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination Oner, Gokalp Ulug, Pasa Elmali, Ferhan Arch Med Sci Clinical Research INTRODUCTION: The aim of this retrospective case control study was to identify predictors of ovarian response and pregnancy outcomes in intrauterine insemination (IUI). MATERIAL AND METHODS: One hundred women undergoing IUI cycles with clomiphene citrate were enrolled. The number of antral follicles and the total ovarian volume by ultrasound, and the basal levels of follicle-stimulating hormone (FSH), estradiol, and inhibin B on cycle day 3 were measured in groups that were divided according to ovarian response. The tests were also evaluated according to ovarian response and pregnancy outcomes. All analyses were performed using the Statistical Package for the Social Sciences, version 15.0 (SPSS, Chicago, IL, USA). RESULTS: The antral follicle count (AFC) was the best single predictor for ovarian response and pregnancy outcomes. The sensitivity and specificity for prediction of ovarian response were 81% and 78% for AFC at an optimum cutoff value of ≤ 13.1. Age was negatively correlated with ovarian volume (r = –0.280, p = 0.021) and AFC (r = –0.358, p = 0.003). Increasing FSH was associated with a reduction in AFC (r = –0.273, p = 0.025). The AFC was significantly correlated with ovarian volume (r = 0.660, p < 0.0001) and FSH (r = –0.273, p = 0.03). CONCLUSIONS: Our data demonstrate that the AFC provides better prognostic information on the occurrence of ovarian response during clomiphene citrate stimulation for IUI. Termedia Publishing House 2015-12-11 2015-12-10 /pmc/articles/PMC4697041/ /pubmed/26788087 http://dx.doi.org/10.5114/aoms.2014.41167 Text en Copyright © 2015 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Clinical Research
Oner, Gokalp
Ulug, Pasa
Elmali, Ferhan
Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination
title Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination
title_full Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination
title_fullStr Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination
title_full_unstemmed Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination
title_short Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination
title_sort ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697041/
https://www.ncbi.nlm.nih.gov/pubmed/26788087
http://dx.doi.org/10.5114/aoms.2014.41167
work_keys_str_mv AT onergokalp ovarianreservemarkersinunexplainedinfertilitypatientstreatedwithclomiphenecitrateduringintrauterineinsemination
AT ulugpasa ovarianreservemarkersinunexplainedinfertilitypatientstreatedwithclomiphenecitrateduringintrauterineinsemination
AT elmaliferhan ovarianreservemarkersinunexplainedinfertilitypatientstreatedwithclomiphenecitrateduringintrauterineinsemination